Early research (Phase 1)Study completedNCT00840879What this trial is testingMeloxicam 15 mg Tablets Under Non-Fasting ConditionsWho this might be right forHealthy Teva Pharmaceuticals USA 28
Early research (Phase 1)Study completedNCT03798561What this trial is testingStudy to Evaluate ASN008 Topical Gel (TG)Who this might be right forDermatitis, AtopicPruritusDermatitis Eczema Asana BioSciences 24
Early research (Phase 1)Active Not RecruitingNCT05739942What this trial is testingDose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent GlioblastomaWho this might be right forNewly Diagnosed and Recurrent Glioblastoma Novartis Pharmaceuticals 42
Large-scale testing (Phase 3)Study completedNCT02181673What this trial is testingGolimumab in Participants With Active Psoriatic ArthritisWho this might be right forArthritis, Psoriatic Janssen Research & Development, LLC 480
Not applicableStudy completedNCT00004556What this trial is testingThe Effects of Dextroamphetamine on Brain FunctionWho this might be right forHealthy National Institute of Mental Health (NIMH) 108
Large-scale testing (Phase 3)Study completedNCT04167462What this trial is testingAn Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South KoreaWho this might be right forPsoriasis Bristol-Myers Squibb 220
Testing effectiveness (Phase 2)Ended earlyNCT00458861What this trial is testingBG9924 in Combination With Methotrexate for Participants With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Biogen 115
Early research (Phase 1)Looking for participantsNCT04872166What this trial is testingBTX-A51 in People With Advanced Solid Tumor and Breast CancerWho this might be right forAdvanced Solid TumorMetastatic Breast Cancer Edgewood Oncology Inc. 112
Early research (Phase 1)Study completedNCT05344729What this trial is testingClinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult SubjectsWho this might be right forRecurrent/Metastatic Breast Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 16
Not applicableUnknownNCT06379646What this trial is testingAn Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseWho this might be right forSystemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Early research (Phase 1)Study completedNCT01648127What this trial is testingPharmacokinetics of Ceftaroline in Normal and Obese SubjectsWho this might be right forDrug Safety Keith A. Rodvold 32
Not applicableStudy completedNCT06000839What this trial is testingA Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology)Who this might be right forSkin FoldSkin LaxitySkin Texture Disorder+6 more Suisselle 41
Testing effectiveness (Phase 2)Study completedNCT02472795What this trial is testingClinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Viatris Innovation GmbH 105
Early research (Phase 1)Study completedNCT05514353What this trial is testingAssess Single and Multiple Ascending Doses of PBI-100 Topical CreamWho this might be right forHealthy VolunteersPsoriasis Pyramid Biosciences 32
Large-scale testing (Phase 3)Study completedNCT00927472What this trial is testingEfficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head LiceWho this might be right forPediculosis Sun Pharmaceutical Industries, Inc. 254
Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Large-scale testing (Phase 3)Study completedNCT02905331What this trial is testingEfficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisWho this might be right forPsoriasis Janssen Research & Development, LLC 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602What this trial is testingAssess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic TherapyWho this might be right forHidradenitis Suppurativa AbbVie 210
Early research (Phase 1)Study completedNCT04136145What this trial is testingSingle Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy SubjectsWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07609472What this trial is testingFG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade GliomaWho this might be right forHigh-Grade Glioma (WHO III-IV) FluoGuide A/S 76